NCI-MATCH arms fall short in ASCO abstracts

Three arms of NCI’s Molecular Analysis for Therapy Choice (NCI-MATCH) tissue agnostic basket trial will report overall response rates (ORR) below 10% at the American Society of Clinical Oncology (ASCO) meeting in Chicago, according to abstracts released ahead of the meeting.

NCI-MATCH is an open-label,

Read the full 448 word article

User Sign In